One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What Are Their Losses?
S. Uytun,S. Eryilmaz Polat,S. Ozkan Tabakci,G. Cinel,N. Emiralioglu,E. Yalcin,N. Kiper,V Sen,D. U. Altintas,H. Cokugras,A. A. Kilinc,H. Yazan, A. Collak,S. Uzuner,G. Unal,A. Yilmaz, S. Celik,E. Damadoglu,I. Irmak,E. Demir,G. Ozturk,E. Basaran,A. Bingol,N. Sapan,A. T. Aslan,P. Asfuroglu,K. Harmanci,M. Kose,M. Hangul,A. Ozdemir,G. Ozcan, Z. G. Gayretli,O. Keskin,H. Yuksel,S. Ozdogan,E. Topal,G. Caltepe,D. Can,P. Korkmaz Ekren,M. Kilic,A. Suleyman,T. Sismanlar Eyuboglu,S. Pekcan,N. Cobanoglu,E. Cakir,U. Ozcelik,D. Dogru EUROPEAN RESPIRATORY JOURNAL（2022）
AI 理解论文
溯源树
样例
